Real-world use of fidaxomicin in a large UK tertiary hospital: how effective is it for treating recurrent disease?
暂无分享,去创建一个
D. Massey | N. Brown | D. Enoch | C. Micallef | M. Murphy | S. Aliyu | R. Santos | C. J. Phillips
[1] K. Carroll,et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] B. Guery,et al. Fidaxomicin for treatment of Clostridium difficile infection in clinical practice: a prospective cohort study in a French University Hospital , 2017, Infection.
[3] M. Salavert,et al. The efficacy of fidaxomicin in the treatment of Clostridium difficile infection in a real-world clinical setting: a Spanish multi-centre retrospective cohort , 2017, European Journal of Clinical Microbiology & Infectious Diseases.
[4] D. Jenkins,et al. The impact of the introduction of fidaxomicin on the management of Clostridium difficile infection in seven NHS secondary care hospitals in England: a series of local service evaluations , 2015, European Journal of Clinical Microbiology & Infectious Diseases.
[5] K. Bauer,et al. An Antimicrobial Stewardship Program's Real‐World Experience with Fidaxomicin for Treatment of Clostridium difficile Infection: A Case Series , 2014, Pharmacotherapy.
[6] D. Gerding,et al. Novel Fidaxomicin Treatment Regimens for Patients With Multiple Clostridium difficile Infection Recurrences That Are Refractory to Standard Therapies , 2014, Open forum infectious diseases.
[7] D. Gerding,et al. Fidaxomicin "chaser" regimen following vancomycin for patients with multiple Clostridium difficile recurrences. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] Derrick W. Crook,et al. Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] D. Crook,et al. Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial. , 2012, The Lancet. Infectious diseases.
[10] Pamela Sears,et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. , 2011, The New England journal of medicine.